Profile | GDS4284 / 239196_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 314.166 | 57 |
GSM687648 | Patient 402 control | 377.891 | 59 |
GSM687653 | Patient 403 control | 268.84 | 55 |
GSM687658 | Patient 404 control | 830.516 | 71 |
GSM687663 | Patient 411 control | 334.124 | 57 |
GSM687668 | Patient 422 control | 578.282 | 66 |
GSM687673 | Patient 424 control | 549.663 | 64 |
GSM687678 | Patient 425 control | 421.149 | 60 |
GSM687683 | Patient 427 control | 487.589 | 62 |
GSM687688 | Patient 428 control | 216.365 | 50 |
GSM687695 | Patient 441 control | 1277.82 | 79 |
GSM687699 | Patient 443 control | 529.459 | 64 |
GSM687704 | Patient 444 control | 339.07 | 58 |
GSM687707 | Patient 448 control | 543.469 | 65 |
GSM687712 | Patient 449 control | 436.564 | 61 |
GSM687719 | Patient 450 control | 1111.03 | 75 |
GSM687724 | Patient 451 control | 333.416 | 57 |
GSM687728 | Patient 452 control | 824.424 | 72 |
GSM687646 | Patient 401 treated 24h | 359.614 | 58 |
GSM687649 | Patient 402 treated 24h | 280.315 | 55 |
GSM687665 | Patient 411 treated 24h | 461.862 | 62 |
GSM687651 | Patient 402 treated 4 weeks | 224.838 | 49 |
GSM687667 | Patient 411 treated 4 weeks | 219.555 | 50 |
GSM687670 | Patient 422 treated 24h | 654.384 | 67 |
GSM687671 | Patient 422 treated 4 weeks | 525.277 | 64 |
GSM687654 | Patient 403 treated 24h | 343.046 | 59 |
GSM687675 | Patient 424 treated 24h | 677.518 | 68 |
GSM687685 | Patient 427 treated 24h | 699.12 | 68 |
GSM687656 | Patient 403 treated 4 weeks | 265.865 | 55 |
GSM687677 | Patient 424 treated 4 weeks | 338.554 | 57 |
GSM687687 | Patient 427 treated 4 weeks | 365.1 | 59 |
GSM687692 | Patient 428 treated 4h | 505.872 | 64 |
GSM687716 | Patient 449 treated 4h | 536.04 | 65 |
GSM687722 | Patient 450 treated 4h | 897.859 | 72 |
GSM687680 | Patient 425 treated 24h | 550.92 | 65 |
GSM687690 | Patient 428 treated 24h | 370.377 | 60 |
GSM687700 | Patient 443 treated 24h | 1091 | 75 |
GSM687705 | Patient 444 treated 24h | 1155.83 | 76 |
GSM687714 | Patient 449 treated 24h | 493.512 | 64 |
GSM687721 | Patient 450 treated 24h | 1330.86 | 79 |
GSM687682 | Patient 425 treated 4 weeks | 391.694 | 60 |
GSM687694 | Patient 428 treated 4 weeks | 329.68 | 58 |
GSM687702 | Patient 443 treated 4 weeks | 369.949 | 57 |
GSM687718 | Patient 449 treated 4 weeks | 385.153 | 60 |
GSM687723 | Patient 450 treated 4 weeks | 461.891 | 62 |
GSM687661 | Patient 404 treated 4h | 806.73 | 71 |
GSM687710 | Patient 448 treated 4h | 83.8008 | 31 |
GSM687726 | Patient 451 treated 4h | 345.656 | 57 |
GSM687730 | Patient 452 treated 4h | 245.356 | 37 |
GSM687660 | Patient 404 treated 24h | 8924.56 | 96 |
GSM687697 | Patient 441 treated 24h | 1006.51 | 75 |
GSM687709 | Patient 448 treated 24h | 314.671 | 56 |
GSM687725 | Patient 451 treated 24h | 597.421 | 66 |
GSM687729 | Patient 452 treated 24h | 1494.62 | 82 |
GSM687727 | Patient 451 treated 4 weeks | 475.833 | 62 |
GSM687731 | Patient 452 treated 4 weeks | 890.7 | 72 |